Om

Curis Inc. is a biotechnology company focused on developing and commercializing innovative therapeutics for cancer treatment. The company’s current portfolio centers on targeted drug candidates designed to address specific cancer-driving pathways and patient groups, with programs spanning hematologic malignancies and solid tumors. Its work includes small-molecule and antibody-based therapies, as well as marketed or advanced-stage assets in oncology and related disease areas. Curis also collaborates with research and development partners to advance its pipeline and expand the clinical profile of its programs. Based in Lexington, Massachusetts, Curis Inc. plays a specialized role in the oncology drug development market, where it contributes to the discovery and testing of precision medicines intended for use in areas with significant unmet medical need.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CURIS MED ENDAVU: Køb Curis ($CRIS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Curis, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.